glp-1 patches fda approved Do really work for weight loss and diabetes? fda-approved glp-1 patches GLP-1 Support
Description
[DOI] [PubMed] [Google Scholar] 27.Gault V.A., Hlscher C
Peak efficacy
GLP-1s are known for disrupting treatment paradigms, but they also expose the cracks in patient access and adherence
Side effects and treatment experience can vary by individual
As endogenous GLP-1 has a very short half-life, these central actions are likely to be more relevant during therapeutic use of DPP4-resistant GLP-1R analogs, or in post-gastric bypass surgeries, in which GLP-1 equivalent levels, or postprandial GLP-1, respectively, are augmented and sufficient to elicit anorectic responses at these CNS targets
